Gout Treatment Research Study

Dr Jessie Lee

Principal Investigator

Gout is a form of inflammatory arthritis. It occurs when excess uric acid in the blood leads to deposits of uric acid crystals in one or more joints. These deposits cause inflammation in your joints. The underlying cause of gout is excess uric acid in the blood – a metabolic disorder called hyperuricemia.

Investigational Treatment

The study will evaluate whether a 12-month course of an investigational drug, called tigulixostat, can reduce uric acid levels for people with gout and high uric acid levels.

 

What’s Involved

Your  participation will last between 12 – 14 months, and you will be required to come to our clinic between 14 and 17 times during that period. At each visit you will see the study doctor and then the research team for study assessments

There is no cost for the study medication or care, and you will be compensated for time and travel.

 

Eligibility

You  may be eligible to participate if:

  • You are aged 18- 85
  • You have high uric acid levels
  • You have gout or a history of gout
  • You do NOT consume more than 14 beers or the equivalent per week

Further eligibility criteria apply.

Register your interest in this study here.
If you would like to learn more about participating in the study please enter your details below and we will be in touch shortly.






    Get in touch with Momentum to deliver your next clinical study

    We work with pharmaceutical companies, contract research organisations and academic research institutes to make clinical trials available to patients.

    REGISTER YOUR INTEREST